|Vaccines Being Scheduled||Not Yet Eligible|
|–Phase 1a (Healthcare Workers; Long-term Care Residents)
–Phase 1b (Residents 65+; Residents 16-64 w/ Medical Conditions & Disabilities; Frontline Essential Workers)
–Phase 1c (Other Essential Workers)Details for Phase 1a, Phase 1b and Phase 1c
|–General Public — Assuming the necessary supply of vaccine is received on schedule, Arlington County will hopefully be able to reach Phase 2 and open eligibility to the general public the week of April 18.
Everyone who lives or works in Virginia should pre-register by visiting vaccinate.virginia.gov or by calling 877-VAX-IN-VA (877-829-4682) so they can be notified when they are eligible.
Updated: April 8, 2021
|Programación para recibir la vacuna||Aún no elegible|
|-Fase 1a: (trabajadores de la salud; residentes que reciben atención a largo plazo)
-Fase 1b: (residentes de 65 años o más; residentes de 16 a 64 años con condiciones médicas y discapacidades; trabajadores esenciales de primera línea)
-Fase 1c: (otros trabajadores esenciales)
|-Público en general: en el supuesto caso de que el suministro necesario de las vacunas se reciba tal como está previsto, el condado de Arlington espera poder alcanzar la Fase 2 y ampliar la elegibilidad al público en general en la semana del 18 de abril.
Todas las personas que viven o trabajan en Virginia deben realizar una preinscripción en el sitio web vaccinate.virginia.gov o llamando al 877-VAX-IN-VA (877-829-4682) y de esta forma se les avisará cuando sean elegibles.
Actualizado: 8 de abril de 2021
NOTE: Vaccines for individuals and eligible essential worker groups will be distributed in parallel.
Vaccine Information for the General Public
On April 1, 2021, Governor Ralph Northam announced that all individuals in Virginia age 16 and older will be eligible to get the COVID-19 vaccine starting on Sunday, April 18, ahead of the May 1 nationwide goal set by President Joe Biden.
What does this mean for Arlington?
- Based on an influx of vaccine supply at the state level, the Virginia Department of Health (VDH) has allocated an increase in local supply of vaccine to complete Arlington County’s aggressive vaccination schedule for the next three weeks in an effort to move to Phase 2.
- VDH has indicated all local health districts, including Arlington, will have enough vaccine to complete outreach to priority groups by the week of April 18. Assuming that the necessary supply is received on schedule, we will hopefully then be able to reach Phase 2 open eligibility to the general public.
- Those at highest risk will continue to receive priority in the scheduling process.
- We anticipate being able to send scheduling notifications to everyone pre-registered in Phase 1C by mid-April.
- We are committed to ensuring everyone on our priority pre-registration lists are notified to schedule appointments prior to going to Phase 2.
Everyone who lives or works in Virginia should pre-register so they can be notified when they are eligible for vaccination and vaccine is available.
- To pre-register, visit vaccinate.virginia.gov or call 877-VAX-IN-VA (877-829-4682, TTY users call 7-1-1).
- If you have already pre-registered, please ensure your information is updated and complete.
- All who have pre-registered should periodically check spam/junk folders for a notification to schedule a vaccine. Emails from Arlington County’s Public Health Division will come from firstname.lastname@example.org, with the subject line “Invitation to Schedule COVID-19 Vaccine Appointment.”
- Anyone who is eligible for a vaccine can use vaccinefinder.org to fine COVID-19 Vaccines near them
The FDA is overseeing the approval process for vaccines. It has released safety and efficacy guidelines for companies working on a vaccine. COVID-19 vaccines under development and in trials must follow the same rigorous safety rules as any other new vaccine.
In addition, the FDA and CDC officials will continue monitoring the safety of vaccines after they are made available to make sure there are no previously detected side effects. Common side effects include pain and swelling n the arm where you got the shot, and fever, chills, tiredness and headache throughout the rest of your body.
If the CDC and FDA identify a problem with a vaccine, the agencies inform health officials, health care providers, and the public. CDC uses several systems to monitor vaccine safety, including V-safe.
V-safe is a new, cell phone-based CDC system that individual COVID-19 vaccine recipients can use to notify CDC if they develop any side effects. Each vaccinated person can and should register for v-safe after receiving the vaccine.
- CDC: What to Expect after Getting a COVID-19 Vaccine
- VDH: How will the COVID-19 vaccine’s safety be monitored?
- VDH: How was the COVID-19 vaccine developed, approved and manufactured
- CDC: Ensuring the Safety of COVID-19 Vaccines in the United States
Ongoing Mitigation Efforts
Receiving the COVID-19 vaccine is just one part of the effort to reduce the spread of the virus. Even after you are vaccinated, you will still need to practice these prevention steps:
- Wash your hands
- Wear a face covering
- Keep at least 6 feet of physical distance from others
- Stay home if sick